Correlation Between Effector Therapeutics and Hepion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Effector Therapeutics and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Effector Therapeutics and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and Hepion Pharmaceuticals.
Diversification Opportunities for Effector Therapeutics and Hepion Pharmaceuticals
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Effector and Hepion is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and Hepion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Effector Therapeutics and Hepion Pharmaceuticals
Given the investment horizon of 90 days Effector Therapeutics is expected to under-perform the Hepion Pharmaceuticals. In addition to that, Effector Therapeutics is 1.83 times more volatile than Hepion Pharmaceuticals. It trades about -0.16 of its total potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about -0.07 per unit of volatility. If you would invest 340.00 in Hepion Pharmaceuticals on August 27, 2024 and sell it today you would lose (274.00) from holding Hepion Pharmaceuticals or give up 80.59% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 59.68% |
| Values | Daily Returns |
Effector Therapeutics vs. Hepion Pharmaceuticals
Performance |
| Timeline |
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Hepion Pharmaceuticals |
Effector Therapeutics and Hepion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Effector Therapeutics and Hepion Pharmaceuticals
The main advantage of trading using opposite Effector Therapeutics and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |